Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today is holding the grand opening of its new, 45,000-square-foot global headquarters facility in downtown St. Louis.
Located in the renovated historic Globe Building in St. Louis’s growing Downtown North Urban Insight District, the new global corporate headquarters is an all-in-one facility offering high-tech research and development, advanced manufacturing, and distribution space for the company’s pipeline of cutting-edge robotic surgery technologies. Stereotaxis, which employs over 130 professionals in ten countries globally, designed its headquarters to accommodate significant long-term growth.
The grand opening celebration and news conference today is planned to include remarks and a tour of the facilities, including hands-on demonstrations of the Robotic Magnetic Navigation technology that has been used in over a hundred hospitals globally to treat more than 100,000 patients. Distinguished guests joining for the Grand Opening include: Missouri Governor, Mike Parson; St. Louis Board of Alderman President, Lewis Reed; Executive Director of the St. Louis Development Corp., Neal Richardson; St. Louis Ward 5 Alderman, James Page; Globe Building Managing Partner, Steve Stone; and Co-Founder and Managing Partner of The Starwood Group, John Berglund. The event will be emceed by CEO of Community Development Ventures, Inc., Dick Fleming. David Fischel and Governor Parson will demonstrate Stereotaxis’ robotic surgical technology in one of the headquarters’ interventional operating rooms in which doctors are trained on the equipment.
“Stereotaxis is delighted to inaugurate a modern new headquarters that serves as a foundation for years of progress and growth,” said Chairman and CEO, David Fischel. “We appreciate the many community leaders who have supported a growing, high-tech innovation ecosystem in St. Louis. We look forward to contributing to the revitalization of downtown St. Louis and pioneering innovations that improve endovascular surgery.”